European Journal of Plastic Surgery

, Volume 30, Issue 1, pp 7–9

What is the role of CT staging in the management of patients with clinical stage 1 and 2 malignant melanoma?

  • Emily Newton-Dunn
  • Matthew Kok-Hao Hong
  • Michael Kok-Yee Hong
  • Christopher Stone
Original Paper
  • 28 Downloads

Abstract

There is a lack of evidence to support CT staging for distant disease in patients with Clinical Stage I and II melanoma. Staging scans, undertaken prior to Sentinel Lymph Node Biopsy (SLNB) in 115 patients with melanoma, between October 2004 and October 2006 were reviewed. CT imaging failed to identify distant site disease in any patient. 67 patients were diagnosed with non-melanoma related abnormalities necessitating further imaging and investigation, ultimately without identifiable benefit in all but one patient. The results of this study further question the need for distant site imaging of melanoma patients prior to SLNB.

Keywords

Malignant melanoma Computerised tomography Management of patients 

References

  1. 1.
    Balch CM et al (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas. Ann Surg Oncol 7:87–97PubMedCrossRefGoogle Scholar
  2. 2.
    Bovio S et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Investig 29:298–302Google Scholar
  3. 3.
    Buzaid AC, Sandier AB, Mani S et al (1993) Role of computerised tomography in the staging of primary melanoma. J Clin Oncol 11:638–643PubMedGoogle Scholar
  4. 4.
    Buzaid AC, Tinoco L, Ross MI et al (1995) Role of computerised tomography in the staging of patients with loco-regional metastases of melanoma. J Clin Oncol 13:2104–2108PubMedGoogle Scholar
  5. 5.
    Ferreira E et al (2005) Prevalence of adrenal incidentaloma at computerised tomography (chest and abdominal) in a general hospital in Brazil. Arq Bras Endocrinol Metabol 49:769–775 (Abstract)PubMedGoogle Scholar
  6. 6.
    Meir F et al (2002) Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 147:62–70CrossRefGoogle Scholar
  7. 7.
    Morton DL, Thompson JF, Cochran AJ (2006) Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317PubMedCrossRefGoogle Scholar
  8. 8.
    National Collaborating Centre for Cancer (2006) Improving outcomes for people with skin tumours including melanoma. National Institute for Clinical Excellence, LondonGoogle Scholar
  9. 9.
    Newton-Bishop JA, Corrie PG, Evans J et al (2002) UK guidelines for the management of cutaneous melanoma. Br J Plast Surg 55:46–54CrossRefGoogle Scholar
  10. 10.
    Shoaib T, Dunn R, Soutar D (2002) UK guidelines for the management of cutaneous melanoma. Br J Plast Surg 55:706–707PubMedCrossRefGoogle Scholar
  11. 11.
    The Royal College of Radiologists (2003) Making the best use of a department of clinical radiology: guidelines for doctors (5th edn.). RCR, LondonGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Emily Newton-Dunn
    • 1
  • Matthew Kok-Hao Hong
    • 1
  • Michael Kok-Yee Hong
    • 1
  • Christopher Stone
    • 1
  1. 1.Department of Plastic SurgeryRoyal Devon and Exeter HospitalDevonUK

Personalised recommendations